open access

Vol 30, No 6 (2023)
Original Article
Submitted: 2021-07-16
Accepted: 2021-10-10
Published online: 2021-12-28
Get Citation

Association between dose of catecholamines and markers of organ injury early after out-of-hospital cardiac arrest

Katarzyna Czerwińska-Jelonkiewicz12, Alice Wood3, Allan Bohm4, Przemysław Kwasiborski5, Anna Oleksiak6, Robert Ryczek7, Johannes Grand8, Guido Tavazzi9, Alessandro Sionis10, Janina Stępińska6
·
Pubmed: 34967939
·
Cardiol J 2023;30(6):946-956.
Affiliations
  1. Division of Cardiology, Andrzej Frycz Modrzewski Krakow University, Krakow, Poland
  2. Intensive Therapy Unit, Harefield Hospital, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom
  3. University Hospitals of Leicester, United Kingdom
  4. Department of Acute Cardiology, National Institute of Cardiovascular Diseases, Bratislava, Slovakia
  5. Third Department of Internal Diseases and Cardiology, Warsaw Medical University, Warsaw, Poland
  6. Department of Intensive Cardiac Therapy, National Institute of Cardiology, Warsaw, Poland
  7. Department of Cardiology, Military Institute of Medicine, Warsaw, Poland
  8. Department of Cardiology, University Hospital of Copenhagen, Denmark
  9. Department of Clinical Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Italy
  10. Intensive Cardiac Care Unit Cardiology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

open access

Vol 30, No 6 (2023)
Original articles — Clinical cardiology
Submitted: 2021-07-16
Accepted: 2021-10-10
Published online: 2021-12-28

Abstract

Background: Catecholamines are recommended as first-line drugs to treat hemodynamic instability
after out-of-hospital cardiac arrest (OHCA). The benefit-to-risk ratio of catecholamines is dose dependent,
however, their effect on metabolism and organ function early after OHCA has not been investigated.
Methods: The Post-Cardiac Arrest Syndrome (PCAS) pilot study was a prospective, observational,
multicenter study. The primary outcomes of this analysis were association between norepinephrine/
/cumulative catecholamines doses and neuron specific enolase (NSE)/lactate concentration over the first
72 hours after resuscitation. The association was adjusted for proven OHCA mortality predictors and
verified with propensity score matching (PSM).
Results: Overall 148 consecutive OHCA patients; aged 18–91 (62.9 ± 15.27), 41 (27.7%) being female,
were included. Increasing norepinephrine and cumulative catecholamines doses were significantly associated
with higher NSE concentration on admission (r = 0.477, p < 0.001; r = 0.418, p < 0.001) and
at 24 hours after OHCA (r = 0.339, p < 0.01; r = 0.441, p < 0.001) as well as with higher lactate concentration
on admission (r = 0.404, p < 0.001; r = 0.280, p < 0.01), at 24 hours (r = 0.476, p < 0.00;
r = 0.487, p < 0.001) and 48 hours (r = 0.433, p < 0.01; r = 0.318, p = 0.01) after OHCA. The associations
remained significant up to 48 hours in non-survivors after PSM.
Conclusions: Increasing dose of catecholamines is associated with higher lactate and NSE concentration,
which may suggest their importance for tissue oxygen delivery, anaerobic metabolism, and organ
function early after OHCA.

Abstract

Background: Catecholamines are recommended as first-line drugs to treat hemodynamic instability
after out-of-hospital cardiac arrest (OHCA). The benefit-to-risk ratio of catecholamines is dose dependent,
however, their effect on metabolism and organ function early after OHCA has not been investigated.
Methods: The Post-Cardiac Arrest Syndrome (PCAS) pilot study was a prospective, observational,
multicenter study. The primary outcomes of this analysis were association between norepinephrine/
/cumulative catecholamines doses and neuron specific enolase (NSE)/lactate concentration over the first
72 hours after resuscitation. The association was adjusted for proven OHCA mortality predictors and
verified with propensity score matching (PSM).
Results: Overall 148 consecutive OHCA patients; aged 18–91 (62.9 ± 15.27), 41 (27.7%) being female,
were included. Increasing norepinephrine and cumulative catecholamines doses were significantly associated
with higher NSE concentration on admission (r = 0.477, p < 0.001; r = 0.418, p < 0.001) and
at 24 hours after OHCA (r = 0.339, p < 0.01; r = 0.441, p < 0.001) as well as with higher lactate concentration
on admission (r = 0.404, p < 0.001; r = 0.280, p < 0.01), at 24 hours (r = 0.476, p < 0.00;
r = 0.487, p < 0.001) and 48 hours (r = 0.433, p < 0.01; r = 0.318, p = 0.01) after OHCA. The associations
remained significant up to 48 hours in non-survivors after PSM.
Conclusions: Increasing dose of catecholamines is associated with higher lactate and NSE concentration,
which may suggest their importance for tissue oxygen delivery, anaerobic metabolism, and organ
function early after OHCA.

Get Citation

Keywords

catecholamines, cardiac arrest, out-of-hospital cardiac arrest, metabolism after cardiac arrest, organ failure after cardiac arrest

Supp./Additional Files (1)
Supplementary Figure 1. Results of propensity score matching according to SOFA score on admission in study cohort (in-hospital survivors vs non-survivors).
View
176KB
About this article
Title

Association between dose of catecholamines and markers of organ injury early after out-of-hospital cardiac arrest

Journal

Cardiology Journal

Issue

Vol 30, No 6 (2023)

Article type

Original Article

Pages

946-956

Published online

2021-12-28

Page views

1593

Article views/downloads

499

DOI

10.5603/CJ.a2021.0173

Pubmed

34967939

Bibliographic record

Cardiol J 2023;30(6):946-956.

Keywords

catecholamines
cardiac arrest
out-of-hospital cardiac arrest
metabolism after cardiac arrest
organ failure after cardiac arrest

Authors

Katarzyna Czerwińska-Jelonkiewicz
Alice Wood
Allan Bohm
Przemysław Kwasiborski
Anna Oleksiak
Robert Ryczek
Johannes Grand
Guido Tavazzi
Alessandro Sionis
Janina Stępińska

References (32)
  1. Nolan JP, Soar J, Cariou A, et al. European Resuscitation Council and European Society of Intensive Care Medicine 2015 guidelines for post-resuscitation care. Intensive Care Med. 2015; 41(12): 2039–2056.
  2. Berg KM, Soar JM, Andersen LW, et al. Adult Advanced Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation. 2020; 142(16_suppl_1): S92–S9S139.
  3. Dellinger R, Levy M, Carlet J, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008; 36(1): 296–327.
  4. Dünser MW, Hasibeder WR. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med. 2009; 24(5): 293–316.
  5. Asfar P, Hauser B, Radermacher P, et al. Catecholamines and vasopressin during critical illness. Crit Care Clin. 2006; 22(1): 131–49, vii.
  6. Cooper BE. Review and update on inotropes and vasopressors. AACN Adv Crit Care. 2008; 19(1): 5–13; quiz 14.
  7. Bouhemad B, Nicolas-Robin A, Arbelot C, et al. Isolated and reversible impairment of ventricular relaxation in patients with septic shock. Crit Care Med. 2008; 36(3): 766–774.
  8. Monge García MI, Santos A, Diez Del Corral B, et al. Noradrenaline modifies arterial reflection phenomena and left ventricular efficiency in septic shock patients: A prospective observational study. J Crit Care. 2018; 47: 280–286.
  9. Stamm C, Friehs I, Cowan D, et al. Dopamine treatment of postischemic contractile dysfunction rapidly induces calcium-dependent pro-apoptotic signaling. Circulation. 2002; 106(12_suppl_1).
  10. Vasquez A, Kern KB, Hilwig RW, et al. Optimal dosing of dobutamine for treating post-resuscitation left ventricular dysfunction. Resuscitation. 2004; 61(2): 199–207.
  11. Iscimen R, Cartin-Ceba R, Yilmaz M, et al. Risk factors for the development of acute lung injury in patients with septic shock: an observational cohort study. Crit Care Med. 2008; 36(5): 1518–1522.
  12. De Backer D, Creteur J, Silva E, et al. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med. 2003; 31(6): 1659–1667.
  13. Aninat C, Seguin P, Descheemaeker PN, et al. Catecholamines induce an inflammatory response in human hepatocytes. Crit Care Med. 2008; 36(3): 848–854.
  14. von Känel R, Dimsdale JE. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol. 2000; 65(6): 357–369.
  15. Ensinger H, Weichel T, Lindner KH, et al. Are the effects of noradrenaline, adrenaline and dopamine infusions on VO2 and metabolism transient? Intensive Care Med. 1995; 21(1): 50–56.
  16. Czerwińska-Jelonkiewicz K, Grand J, Tavazzi G, et al. Acute respiratory failure and inflammatory response after out-of-hospital cardiac arrest: results of the Post-Cardiac Arrest Syndrome (PCAS) pilot study. Eur Heart J Acute Cardiovasc Care. 2020; 9(4_suppl): S110–S121.
  17. Ferreira FL, Bota DP, Bross A, et al. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001; 286(14): 1754–1758.
  18. Langhelle A, Nolan J, Herlitz J, et al. Recommended guidelines for reviewing, reporting, and conducting research on post-resuscitation care: the Utstein style. Resuscitation. 2005; 66(3): 271–283.
  19. Laurikkala J, Wilkman E, Pettilä V, et al. Mean arterial pressure and vasopressor load after out-of-hospital cardiac arrest: Associations with one-year neurologic outcome. Resuscitation. 2016; 105: 116–122.
  20. Kakavas S, Chalkias A, Xanthos T. Vasoactive support in the optimization of post-cardiac arrest hemodynamic status: from pharmacology to clinical practice. Eur J Pharmacol. 2011; 667(1-3): 32–40.
  21. Overgaard CB, Dzavík V. Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease. Circulation. 2008; 118(10): 1047–1056.
  22. Tilley DG, Rockman HA. Role of beta-adrenergic receptor signaling and desensitization in heart failure: new concepts and prospects for treatment. Expert Rev Cardiovasc Ther. 2006; 4(3): 417–432.
  23. Modest VE, Butterworth JF. Effect of pH and lidocaine on beta-adrenergic receptor binding. Interaction during resuscitation? Chest. 1995; 108(5): 1373–1379.
  24. Jhanji S, Stirling S, Patel N, et al. The effect of increasing doses of norepinephrine on tissue oxygenation and microvascular flow in patients with septic shock. Crit Care Med. 2009; 37(6): 1961–1966.
  25. De Backer D, Creteur J, Dubois MJ, et al. The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med. 2006; 34(2): 403–408.
  26. Levy B, Bollaert PE, Charpentier C, et al. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med. 1997; 23(3): 282–287.
  27. Levy B. Lactate and shock state: the metabolic view. Curr Opin Crit Care. 2006; 12(4): 315–321.
  28. Kliegel A, Losert H, Sterz F, et al. Serial lactate determinations for prediction of outcome after cardiac arrest. Medicine (Baltimore). 2004; 83(5): 274–279.
  29. Arnold RC, Shapiro NI, Jones AE, et al. Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock. 2009; 32(1): 35–39.
  30. Engrand N, Lebard C, Luis D, et al. Return of spontaneous circulation after an out-of-hospital cardiac arrest: An acute brain injury like others? Resuscitation. 2020; 153: 268–269.
  31. Sandroni C, D'Arrigo S, Nolan JP. Prognostication after cardiac arrest. Crit Care. 2018; 22(1): 150.
  32. Ameloot K, De Deyne C, Eertmans W, et al. Early goal-directed haemodynamic optimization of cerebral oxygenation in comatose survivors after cardiac arrest: the Neuroprotect post-cardiac arrest trial. Eur Heart J. 2019; 40(22): 1804–1814.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl